Purpose: The purpose of RTOG 97–12 was to determine the maximum tolerated dose (MTD)
of thoracic radiation therapy (RT) with concurrent chemotherapy for patients with limited …

PURPOSE: To investigate whether high-dose thoracic radiation given twice daily during
cisplatin-etoposide chemotherapy for limited small-cell lung cancer (LSCLC) improves …

PURPOSE: To fit the situation of developing countries, where supportive care is not
sufficient, a modified combined therapy of cisplatin/etoposide (EP) and hyperfractionated …

PURPOSE: To prospectively evaluate the feasibility of delivering 70 Gy once-daily thoracic
radiotherapy (TRT), concurrent with chemotherapy, in the treatment of limited-stage small …

PURPOSE This pilot study was undertaken to determine the efficacy and feasibility of
alternating cisplatin and etoposide with multiple daily fractions of thoracic radiotherapy …

PURPOSE An improvement in radiation dose schedule is necessary to increase local tumor
control and survival in limited-stage small-cell lung cancer. The goal of this study was to …

PURPOSE To provide a 10-year update of the experience of the Cancer and Leukemia
Group B (CALGB) in the addition of thoracic radiation therapy to chemotherapy in limited …

Purpose: To assess the impact of age on the delivery, tolerance, and efficacy of thoracic
irradiation (TI) for limited small cell lung cancer (L-SCLC). Methods and Materials: This is a …

PURPOSE: To perform a retrospective review of a single institution's 10-year experience in
treating limited-stage small-cell lung cancer (LS-SCLC) with a concurrent chemoradiation …

Purpose To evaluate the outcome of patients with limited-stage small-cell lung cancer (L-
SCLC) treated with cisplatin and etoposide (PE), early prophylactic cranial irradiation (PCI) …